Evidence map›Paper›PMID 25807199›Full record

ArticleCancer biology & therapy2015

Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.

Jussuf T Kaifi, Miriam Kunkel, Avisnata Das, Ramdane A Harouaka, David T Dicker, Guangfu Li, Junjia Zhu, Gary A Clawson, Zhaohai Yang, Michael F Reed and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in Cancer biology & therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01722903 (Perioperative Detection and Characterization of Circulating Tumor Cells in Patients Undergoing Colorectal Cancer Liver and Lung Metastasectomy), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01722903 completednot on this map

Perioperative Detection and Characterization of Circulating Tumor Cells in Patients Undergoing Colorectal Cancer Liver and Lung Metastasectomy

TypeobservationalSponsorMilton S. Hershey Medical CenterRan2012 to 2015Enrolled25ConditionsStage IV Colorectal Cancer, Liver Metastases, Lung Metastases
3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Trial
  2. Circulating Tumor Cells: Emerging Frontiers in Cancer Technology.Expert reviews in molecular medicine · 2026
    Review
  3. Review
  4. Liquid biopsies in cancer.Molecular biomedicine · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Metastasis and MAPK Pathways.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jussuf T Kaifia Program for Liver, Pancreas and Foregut (Lung & Esophageal) Tumors; Department of Surgery (Surgical Oncology).
Miriam Kunkel
Avisnata Das
Ramdane A Harouaka
David T Dicker
Guangfu Li
Junjia Zhu
Gary A Clawson
Zhaohai Yang
Michael F Reed
Niraj J Gusani
Eric T Kimchi
Kevin F Staveley-O'Carroll
Si-Yang Zheng
Wafik S El-Deiry

Funding

Immunopheonotyping of circulating tumor cellsR21CA181419 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI EL-DEIRY, WAFIK S. · 2014 to 2015
$403k
NCI NIH HHS R21 CA181419
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) metastasectomy improves survival, however most patient develop recurrences. Circulating tumor cells (CTCs) are an independent prognostic marker in stage IV CRC. We hypothesized that CTCs can be enriched during metastasectomy applying different isolation techniques.

methods25 CRC patients undergoing liver (16 (64%)) or lung (9 (36%)) metastasectomy were prospectively enrolled (clinicaltrial.gov identifier: NCT01722903). Central venous (liver) or radial artery (lung) tumor outflow blood (7.5 ml) was collected at incision, during resection, 30 min after resection, and on postoperative day (POD) 1. CTCs were quantified with 1. EpCAM-based CellSearch® system and 2. size-based isolation with a novel filter device (FMSA). CTCs were immunohistochemically identified using CellSearch®'s criteria (cytokeratin 8/18/19+, CD45- cells containing a nucleus (DAPI+)). CTCs were also enriched with a centrifugation technique (OncoQuick®).

resultsCTC numbers peaked during the resection with the FMSA in contrast to CellSearch® (mean CTC number during resection: FMSA: 22.56 (SEM 7.48) (p = 0.0281), CellSearch®: 0.87 (SEM ± 0.44) (p = 0.3018)). Comparing the 2 techniques, CTC quantity was significantly higher with the FMSA device (range 0-101) than CellSearch® (range 0-9) at each of the 4 time points examined (P < 0.05). Immunofluorescence staining of cultured CTCs revealed that CTCs have a combined epithelial (CK8/18/19) and macrophage (CD45/CD14) phenotype.

conclusionsBlood sampling during CRC metastasis resection is an opportunity to increase CTC capture efficiency. CTC isolation with the FMSA yields more CTCs than the CellSearch® system. Future studies should focus on characterization of single CTCs to identify targets for molecular therapy and immune escape mechanisms of cancer cells.

Indexed as

AdultAgedAged, 80 and overColorectal NeoplasmsFemaleHumansLiver NeoplasmsLung NeoplasmsMaleMiddle AgedNeoplasm MetastasisNeoplastic Cells, CirculatingProspective Studiescirculating tumor cellscolorectal cancerCRC, Colorectal CancerCTCs, Circulating Tumor CellsEpCAM, Epithelial Cell Adhesion MoleculeFMSA, Flexible Micro Spring Arrayliver metastasislung metastasesstage IV

Identifiers

PMID25807199
PMCPMC4622016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.